1 active not recruiting, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Neurofibroma Plexiform: new trials by email Literature Review of Neurofibroma Plexiform trials Research Report on Neurofibroma Plexiform
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas PAS-004 Tablets - NF1 Mutation, Neurofibroma Plexiform | Phase 1 | Recruiting | Pasithea Therapeutics Corp. | 56 | 2025-05-30 | 2025-12-04 |
| A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) Selumetinib - Neurofibromatosis 1, Neurofibroma Plexiform | Phase 1 | Active not recruiting | AstraZeneca | 32 | 2020-12-16 | 2026-08-18 |
Neurofibroma, Plexiform (2) · Neurofibromatosis 1 (2) · Neurofibromatoses (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Heredodegenerative Disorders, Nervous System (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Nerve Tissue (2) · Neoplastic Syndromes, Hereditary (2) · Nerve Sheath Neoplasms (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Neurocutaneous Syndromes (2) · Neurodegenerative Diseases (2) · Neurofibroma (2) · Neuromuscular Diseases (2) · Peripheral Nervous System Diseases (2)
AZD 6244 (1)
AstraZeneca (1) · Pasithea Therapeutics Corp. (1)
Australia (1) · China (1) · South Korea (1) · United States (1)
Qingfeng Li (1) · Tiago R Marques, MD (1)